Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mortality Risk Factors in Patients With Covid-19 Infection: A Case-Control Study in Northeast of Iran



Hashemi SA1, 7 ; Naieni KH2 ; Mansournia MA3 ; Akrami R4, 5 ; Nomali M5 ; Valadbeigi T5 ; Mennati W5 ; Adineh HA5, 6 ; Taghavi MR1, 7 ; Ghafouri M1, 7 ; Poorbarat S8 ; Hoseinzadeh A8 ; Farahdel M9 ; Armat MR10 Show All Authors
Authors
  1. Hashemi SA1, 7
  2. Naieni KH2
  3. Mansournia MA3
  4. Akrami R4, 5
  5. Nomali M5
  6. Valadbeigi T5
  7. Mennati W5
  8. Adineh HA5, 6
  9. Taghavi MR1, 7
  10. Ghafouri M1, 7
  11. Poorbarat S8
  12. Hoseinzadeh A8
  13. Farahdel M9
  14. Armat MR10
  15. Haresabadi M5, 11
Show Affiliations
Authors Affiliations
  1. 1. Department of Infectious Diseases, School of Medicine, North KhorasanUniversity of Medical Sciences, Bojnurd, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Epidemiology & Biostatistics, School of Public Health, Sabzevar University of Medical Sciences, Sabzevar, Iran
  5. 5. Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Iranshhar University of Medical Sciences, Iranshahr, Iran
  7. 7. Department of Infectious Diseases, School of Medicine, North KhorasanUniversity of Medical Sciences, Bojnurd, Iran
  8. 8. North Khorasan University of Medical Sciences, Bojnurd, Iran
  9. 9. Imam Hassan Hospital, North Khorasan University of Medical Sciences, Bojnurd, Iran
  10. 10. School of Nursing, North Khorasan University of Medical Sciences, Bojnurd, Iran
  11. 11. Department of Nursing, School of Nursing and, North Khorasan University of Medical Sciences, Bojnurd, Iran

Source: Iranian Journal of Epidemiology Published:2021

Abstract

Background and Objectives: COVID-19 is a new disease and little information is available on its risk factors. The aim of this study was to determine the mortality risk factors in patients with COVID-19 in the northeast of Iran. Materials and Methods: A case-control study was conducted. Patients of both sexes with a confirmed diagnosis of Covid-19 infection who died during the study were studied as the case group and patients who were in good general health and ready for discharge were studied as the control group. Data analysis was performed with the STATA software version 14 using descriptive statistics and univariate and multiple logistic regression tests. Results: Six hundred and eleven patients were studied (27% cases and 73% controls). Multiple logistic regression analysis showed that the odds of death were 2.8 times higher in patients over 80 years compared to patients aged 50-60 years. In addition, age under 40 years reduced the odds of mortality by 85% and living in rural areas increased odds of death by 2.2 times. Cough, general fatigue, pain, nausea and vomiting increased the odds of COVID19 survival. Conclusion: The odds of mortality were higher in elder patients with COVID-19. In addition, living in rural areas increased the odds of mortality in patients. Cough and fatigue reduced mortality; however, it is needed to address other hidden factors for sound judgment. © 2021 The Authors. Published by Tehran University of Medical Sciences.
Other Related Docs
12. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
15. Trend and Prediction of Covid-19 Outbreak in Iran: Seir and Anfis Model, Polish Journal of Medical Physics and Engineering (2021)
31. Effect of Probiotics on Covid-19 Infection: A Systematic Review, Scientific Journal of Kurdistan University of Medical Sciences (2024)
33. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)
38. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)